Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a report issued on Monday. The firm set a “hold” rating on the stock.

Retractable Technologies Trading Up 0.8 %

Shares of RVP stock opened at $0.81 on Monday. The stock has a 50 day simple moving average of $0.78 and a 200-day simple moving average of $0.76. Retractable Technologies has a 1-year low of $0.56 and a 1-year high of $1.30. The company has a market cap of $24.10 million, a price-to-earnings ratio of -1.49 and a beta of 2.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. Wealthfront Advisers LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned about 8.46% of Retractable Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.